The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence
Clinical trial NCT06166615 · UNKNOWN
Trial details
- NCT number
- NCT06166615
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-15
- Primary completion
- 2024-05-30
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.